Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors

References

• Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521–526.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Peman J, Bernhardt H, . Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Kibbler C, Peman J, . Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27: 359–366.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J, . The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin infect Dis 2005; 41: 1232–1239.
   PubMed Web of Science ®Google Scholar
• Morgan J, Meltzer MI, Plikaytis BD, . Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Inf Cont Hosp Epidemiol 2005; 26: 540–547.
   PubMed Web of Science ®Google Scholar
• Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998; 27: 781–788.
   PubMed Web of Science ®Google Scholar
• Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–2645.
   PubMed Web of Science ®Google Scholar
• Leleu G, Aegerter P, Guidet B, Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002; 17: 168–175.
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Lewis RE, Tarrand J, . Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001–2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 2009; 115: 4745–4752.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Segal BH, Kwon-Chung J, Walsh TJ, . Immunotherapy for fungal infections. Clin Infect Dis 2006; 42: 507–515.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, . Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366–1377.
   PubMed Web of Science ®Google Scholar
• Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309–316.
   PubMed Web of Science ®Google Scholar
• Vigouroux S, Morin O, Moreau P, Harousseau JL, Milpied N. Candidemia in patients with hematologic malignancies: analysis of 7 years’ experience in a single center. Hematologica 2006; 91: 717–718.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodstream infections in the U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin infect Dis 2004; 39: 309–317.
   PubMed Web of Science ®Google Scholar
• Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112: 2493–2499.
   PubMed Web of Science ®Google Scholar
• Antoniadou A, Torres HA, Lewis RE, . Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 2003; 82: 309–321.
   PubMed Web of Science ®Google Scholar
• Slavin MA, Sorrell TC, Marriott D, . Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 2010; 65: 1042–1051.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, . Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. Diagn Microbiol Infect Dis 2004; 50: 113–117.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Candoni A, . The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068–1075.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: 954–966.
   PubMed Web of Science ®Google Scholar
• Reboli AC, Rotstein C, Pappas PG, . Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356: 2472–2482.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rotstein CMF, Betts RF. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007; 45: 883–893.
   PubMed Web of Science ®Google Scholar
• Poikonen E, Lyytikäinen O, Anttila VJ, . Secular trend in candidemia and the use of fluconazole in Finland, 2004–2007. BMC Infect Dis 2010; 10: 312.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodriguez D, Park BJ, . Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005; 43: 1829–1835.
   PubMed Web of Science ®Google Scholar
• Cisterna R, Ezpeleta G, Telleria O, . A nationwide sentinel surveillance of bloodstream Candida spp. infections sudy in 40 tertiary-care hospitals in Spain. J Clin Microbiol 2010; 48: 4200–4206.
   PubMed Web of Science ®Google Scholar